GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced a new initiative at Walgreens to reduce prices on nearly 200 prescription medications by an average of 40%, with even greater savings available for select medications. Consumers can…
Today, MLCommons, the leading open AI engineering consortium, announced new results from two MLPerf™ benchmark suites: MLPerf Inference v3.1, which delivers industry standard Machine Learning (ML) system performance benchmarking in an architecture-neutral, representative, and reproducible manner, and MLPerf Storage v0.5.…
Exai Bio today announced non-small cell lung cancer (NSCLC) data further validating that its novel RNA- and generative AI-based liquid biopsy platform detected early-stage disease with high accuracy. The study of nearly 900 subjects demonstrated stage I sensitivity was 95%…
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer (CFO) and Treasurer, effective September 25, 2023. Ms. Robertson’s appointment follows the retirement of Olivia Bloom, Geron’s…
Novartis today announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave the company and will step down from the Executive Committee of Novartis (ECN), effective September 15, after nearly seven years of commercial…
Sandoz today published a supplement to its Listing Prospectus of August 18, 2023, ahead of an Extraordinary General Meeting (EGM) of Novartis shareholders. Scheduled to take place on September 15, 2023, the EGM has been called after the Novartis Board…
Optum, a diversified health services company, and Capella University, an accredited online university, announced a new educational program designed to address the growing need for skilled, advanced practice nurses. The collaboration will pair Capella’s unique educational capabilities with Optum’s clinical…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced new, 10-year long-term follow-up (LTFU) data published in the peer reviewed journal, Pediatrics, for girls and boys who received a three-dose regimen of GARDASIL®9 (Human Papillomavirus 9-valent Vaccine,…
Following FDA approval, CVS Pharmacy® is now offering over-the-counter (OTC) naloxone, brand name NARCAN®, at more than 7,500 locations nationwide, making it easier and more discrete than ever to purchase the safe and effective antidote to opioid overdoses. What is naloxone? Available…
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business, and Suneet Varma, Global Oncology and U.S. President, at the…
CerroZone™ LLC’s air purification platforms have become the first to meet and exceed the requirements for Air Purifiers set out in the recently published ASHRAE Standard 241-2023 Control of Infectious Aerosols The same system previously earned 510(k) Class II clearance…
EarliTec Diagnostics, Inc. (“EarliTec”), a digital health company developing novel diagnostic and therapeutic products for children with autism and related early childhood vulnerabilities, today announced that The Journal of the American Medical Association (JAMA) published positive results from a Phase III trial demonstrating…